Asbestos Diseases Research Foundation
1 clinical trials · Sponsor
◉ Watch Asbestos Diseases Research Foundation
| Record | Firm | Date |
|---|---|---|
| MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC (NCT02369198) | Asbestos Diseases Research Foundation | 2014-09-01 |
Track Asbestos Diseases Research Foundation automatically
Every clearance here is in the API, with alerts when new ones post.